Related Articles Encapsulation of Naproxen in Lipid-Based Matrix Microspheres: Characterization and Release Kinetics Investigation of various practical techniques to enhance dissolution of ezetimibe from oral tablets: A comparative study Saroglitazar, a novel cardiometabolic agent for diabetic dyslipidemia – A Review Documentation and Records: Harmonized GMP Requirements An in silico approach to design potential siRNA molecules for ICP22 (US1) gene silencing of different strains of human herpes simplex 1 Share 0 FacebookTwitterLinkedinEmail Previous Article Multi Purpose Technology (MPTs)-Expanding the Horizons of Health Care Next Article Saroglitazar, a novel cardiometabolic agent for diabetic dyslipidemia – A Review